11 research outputs found

    Potentiation of the anti-tumour effects of Photofrin®-based photodynamic therapy by localized treatment with G-CSF

    Get PDF
    Photofrin®-based photodynamic therapy (PDT) has recently been approved for palliative and curative purposes in cancer patients. It has been demonstrated that neutrophils are indispensable for its anti-tumour effectiveness. We decided to evaluate the extent of the anti-tumour effectiveness of PDT combined with administration of granulocyte colony-stimulating factor (G-CSF) as well as the influence of Photofrin®and G-CSF on the myelopoiesis and functional activity of neutrophils in mice. An intensive treatment with G-CSF significantly potentiated anti-tumour effectiveness of Photofrin®-based PDT resulting in a reduction of tumour growth and prolongation of the survival time of mice bearing two different tumours: colon-26 and Lewis lung carcinoma. Moreover, 33% of C-26-bearing mice were completely cured of their tumours after combined therapy and developed a specific and long-lasting immunity. The tumours treated with both agents contained more infiltrating neutrophils and apoptotic cells then tumours treated with either G-CSF or PDT only. Importantly, simultaneous administration of Photofrin®and G-CSF stimulated bone marrow and spleen myelopoiesis that resulted in an increased number of neutrophils demonstrating functional characteristics of activation. Potentiated anti-tumour effects of Photofrin®-based PDT combined with G-CSF observed in two murine tumour models suggest that clinical trials using this tumour therapy protocol would be worth pursuing. © 2000 Cancer Research Campaig

    What is at risk? – an environmental health risk assessment related with pharmaceutical substances in drinking water

    No full text
    Constantly increasing rate of drugs’ consumption can be related with environmental abundance of drug substances and their degradation products. Unused and used drugs are often discharged into municipal wastewaters or landfills. Wastewater treatment plants are not able to remove the entire load of drugs. Especially those which occur occasionally or at very low concentrations. Therefore, a variety of pharmaceuticals occur in surface and drinking water sources. A chronic low-level exposure to drugs occurring in a water environment can cause: antibiotic resistance, allergic reactions (eg. Penicillin), cause carcinogenesis (oxytetracycline, furazolidone), nephropathy (gentamicin) and have a negative impact on the natural human intestinal microflora. Therefore, it is not an easy task to assess a common human health effects related with chronic exposure to low doses of active pharmaceutical substances. Nonetheless, such knowledge seems essential in order to undertake preventive actions that would substantially decrease the level of health risk
    corecore